Table 4.

Prevalence of 238 tumor necrosis factor α polymorphism (TNFG, G at position 238; and TNFA, A at position 238), according to subject group

Subject groupTNFG/TNFGTNFG/TNFATNFA/TNFA
Controls (n = 172) 146  (85) 23 (13) 3 (2)  
Patients with HHC (n = 64) 63  (98)4-150  1 (2) 0  
C282Y +/+ patients (n = 38) 37  (97)4-151  1 (3) 0 
Non-C282Y +/+ patients (n = 26) 26  (100)‡  0 0 
Subject groupTNFG/TNFGTNFG/TNFATNFA/TNFA
Controls (n = 172) 146  (85) 23 (13) 3 (2)  
Patients with HHC (n = 64) 63  (98)4-150  1 (2) 0  
C282Y +/+ patients (n = 38) 37  (97)4-151  1 (3) 0 
Non-C282Y +/+ patients (n = 26) 26  (100)‡  0 0 

Values are number (%) of subjects in each group.

See Tables 1 and 2 for abbreviations.

F4-150

P = .0022 compared with controls.

F4-151

P = .0344 compared with controls.

‡

P = .029 compared with controls.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal